WKHS Locations

Clinical Trials

Study Title

Sativex 999

Purpose

To evaluate the safety of long term Sativex therapy when used as an adjunctive (not breakthrough) measure in patients with advanced cancer

Eligibility

Contact Principal Investigator for Information

Study Process

Contact Principal Investigator for Information

Trial Details

Principal Investigator:

Matthew Mosura, M.D.

IRB:

Quorum

IRB Number:

Trial Type:

Drug

Sponsor:

Otsuka / GW Pharma

Contact Information:

River Cities Interventional Pain Specialists
(318) 212-7960